[go: up one dir, main page]

WO2004048518A3 - Organelle-associated proteins - Google Patents

Organelle-associated proteins Download PDF

Info

Publication number
WO2004048518A3
WO2004048518A3 PCT/US2003/037278 US0337278W WO2004048518A3 WO 2004048518 A3 WO2004048518 A3 WO 2004048518A3 US 0337278 W US0337278 W US 0337278W WO 2004048518 A3 WO2004048518 A3 WO 2004048518A3
Authority
WO
WIPO (PCT)
Prior art keywords
orga
organelle
associated proteins
polynucleotides
agonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2003/037278
Other languages
French (fr)
Other versions
WO2004048518A2 (en
Inventor
Brooke M Emerling
David Chien
Jonathan T Wang
Thomas W Richardson
Jayalaxmi Ramkumar
Reena Khare
Vicki S Elliott
Soo Yeun Lee
Umesh G Bhatia
John D Burrill
Sally Lee
Julie J Blake
Anne Ho
Wenjin Zheng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Corp filed Critical Incyte Corp
Priority to AU2003295760A priority Critical patent/AU2003295760A1/en
Publication of WO2004048518A2 publication Critical patent/WO2004048518A2/en
Publication of WO2004048518A3 publication Critical patent/WO2004048518A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Various embodiments of the invention provide human organelle-associated proteins (ORGA) and polynucleotides which identify and encode ORGA. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of ORGA.
PCT/US2003/037278 2002-11-26 2003-11-21 Organelle-associated proteins Ceased WO2004048518A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003295760A AU2003295760A1 (en) 2002-11-26 2003-11-21 Organelle-associated proteins

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US42944502P 2002-11-26 2002-11-26
US60/429,445 2002-11-26
US43083302P 2002-12-03 2002-12-03
US60/430,833 2002-12-03

Publications (2)

Publication Number Publication Date
WO2004048518A2 WO2004048518A2 (en) 2004-06-10
WO2004048518A3 true WO2004048518A3 (en) 2004-11-25

Family

ID=32397200

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/037278 Ceased WO2004048518A2 (en) 2002-11-26 2003-11-21 Organelle-associated proteins

Country Status (2)

Country Link
AU (1) AU2003295760A1 (en)
WO (1) WO2004048518A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1838872A2 (en) * 2004-12-15 2007-10-03 Government of the United States of America as represented by The Secretary of the Department of Health and Human Services Cancer-specific spanx-n markers

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020091244A1 (en) * 1997-12-31 2002-07-11 Incyte Pharmaceuticals, Inc. Human signal peptide-containing proteins

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020091244A1 (en) * 1997-12-31 2002-07-11 Incyte Pharmaceuticals, Inc. Human signal peptide-containing proteins

Also Published As

Publication number Publication date
AU2003295760A8 (en) 2004-06-18
WO2004048518A2 (en) 2004-06-10
AU2003295760A1 (en) 2004-06-18

Similar Documents

Publication Publication Date Title
WO2003052075A3 (en) Enzymes
WO2002063005A3 (en) Lipid-associated molecules
WO2003042357A3 (en) Enzymes
WO2004044165A3 (en) Lipid-associated proteins
WO2002097060A3 (en) Carbohydrate-associated proteins
WO2004053068A3 (en) Protein modification and maintenance molecules
WO2004009797A3 (en) Protein modification and maintenance molecules
WO2003063688A3 (en) Protein modification and maintenance molecules
WO2003068943A3 (en) Secreted proteins
WO2003062391A3 (en) Structural and cytoskeleton-associated proteins
WO2003076586A3 (en) Nucleic acid-associated proteins
WO2002066646A3 (en) Neurotransmission-associated proteins
WO2004003162A3 (en) Enzymes
WO2003083084A3 (en) Protein modification and maintenance molecules
WO2003087300A3 (en) Secreted proteins
WO2003063769A3 (en) Vesicle-associated proteins
WO2003072729A3 (en) Enzymes
WO2003100016A3 (en) Protein modification and maintenance molecules
WO2003093439A3 (en) Enzymes
WO2003083082A3 (en) Enzymes
WO2003025150A3 (en) Lipid-associated molecules
WO2004022705A3 (en) Neurotransmission-associated proteins
WO2004094589A3 (en) Secreted proteins
WO2004007527A3 (en) Secreted proteins
WO2003008625A3 (en) Structural and cytoskeleton-associated proteins

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP